Ultramarine & Pigments Ltd
ULTRAMARUltramarine & Pigments Ltd's earnings have outrun its stock. EPS grew +7.6% in a year against a −8.4% price move.
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.
The price is in a downtrend (50 weeks in) while the P/E sits at the 18th percentile of its own 6-year range. Underneath, the last four quarters read improving — profit +60.0% year on year, and 138% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Ultramarine & Pigments Ltd trades at ₹428, in a downtrend and 50 weeks into that stage. That is +3.2% against its own 200-day average. It sits at 58% of a 52-week range of ₹367 to ₹472. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 4 straight weeks.
Today the stock is in a downtrend — week 50 of stage 4, confirmed. At ₹428 it trades +3.2% versus its 200-day average and sits at 58% of its 52-week range (₹367–₹472).
Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +277% while the NIFTY 500 moved +267% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 4 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Ultramarine & Pigments Ltd trades at 13.9× P/E, near the bottom of its own range — cheaper only 18% of the time. Its long-run median P/E is 16.8×, measured across 6.3 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 13.9× is near the bottom of its own range — cheaper only 18% of the time, against a long-run median of 16.8× measured over 6.3 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +7.6% against a −8.4% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the −1.4%/yr price move, ~+8.5%/yr came from earnings growth and ~−9.9 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.
What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.
Solved at its 13 June 2026 price, Ultramarine & Pigments Ltd was paying for profit growth of about 6.7% a year. Profit itself has compounded 4.6% a year over the past 6 years. Today the market pays 13.9× P/E, the 18th percentile of its own 6-year range.
What the two numbers say together. The multiple is low against its own past, and the growth the price is paying for is close to what this company has actually delivered.
How to hold this number: it is a reading of one day's price, taken on 13 June 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Ultramarine & Pigments Ltd reads as mixed on its fundamental arc. Mixed — no clean majority across the growth curves, ROCE holding at 11.0% — the per-curve reads carry the story. The read is built from 8 quarters across 4 curves, on partial evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +11.5% | +11.6% | +20.3% | — |
| Profit | +8.0% | +5.5% | +7.7% | — |
| EPS | +7.6% | +5.3% | +7.7% | — |
| Share price | −8.4% | +0.4% | −1.4% | +11.8% |
4-Factor Sector Score
66.2/100 — rank 2 of 10 in Dyes & Pigments · 81% evidence confidence
Ultramarine & Pigments Ltd scores 66.2 out of 100 against the 10 companies it is compared with in Dyes & Pigments, ranking 2. Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
The four contributions add to the total exactly: 23 + 17.3 + 13.3 + 12.6 = 66.2. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Ultramarine & Pigments Ltd reported ₹240 Cr of revenue in the Jun 26 quarter, +30.4% year on year. That is the 10th straight quarter of year-on-year growth. Over 6 years it has compounded at 16.8% a year. The last full year, FY26, came in at ₹775 Cr. The last four reported quarters add to ₹831 Cr.
FY26 revenue came in at ₹775 Cr (+11.5% on the year), capping 6 years at 16.8% compound. The latest quarter (Jun 26) printed ₹240 Cr, +30.4% year on year — the 10th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +15.9% growth against the decade's 16.8% — the current year is running in line with its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +15.6% over the last 4 quarters against +18.6%/yr over the last 8 — rolling over; TTM profit +16.5% vs +25.9%/yr — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Ultramarine & Pigments Ltd's operating margin is 19.0% in the Jun 26 quarter, +2.0 percentage points against the same quarter a year ago. Across 7 fiscal years the operating margin has ranged 16.0% to 25.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 19.0%, +2.0 pp against the same quarter a year ago. Across 7 fiscal years the operating margin has ranged 16.0%–25.0%.
Why the margin moved: operating margin went +1.7 pp year on year while gross margin went −1.0 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Ultramarine & Pigments Ltd earned ₹32.0 Cr of net profit in the Jun 26 quarter, +60.0% year on year. Full-year FY26 profit was ₹81.0 Cr. The 6-year compound rate is 4.6%. That is 13.3% of the quarter's revenue. The same quarter a year earlier earned ₹20.0 Cr.
Jun 26 profit was ₹32.0 Cr, +60.0% year on year. On the full year, FY26 printed ₹81.0 Cr (+8.0%), and the 6-year compound rate is 4.6%.
Why profit moved: revenue contributed +30.4% and the margin +2.0 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +14.9% vs revenue +15.9%. Profit and revenue are moving roughly in step.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 138% of Ultramarine & Pigments Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹128 Cr of operating cash against ₹81.0 Cr of profit. After ₹70.0 Cr of capital spending, ₹58.0 Cr was left as free cash.
FY26: operating cash of ₹128 Cr against reported profit of ₹81.0 Cr, leaving free cash of ₹58.0 Cr after ₹70.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 138% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 138%: the cash cycle held roughly steady between FY21 and FY26 — so conversion tracks profitability rather than the cycle.
Router verdict: the bigger cash user is investment — capital spending ran 2.9× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Ultramarine & Pigments Ltd's cash conversion cycle runs 56 days in FY26, up from 54 days in FY21. Capital spending ran ₹209 Cr over the last 3 years. At FY26 sales of ₹775 Cr each day of that cycle holds about ₹2.1 Cr, so roughly ₹119 Cr sits inside the business at any moment.
FY26: debtors at 38 days, inventory at 88 days — roughly 2.9 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 56 days, looser than FY21's 54.
The full loop: cash goes out to suppliers and production on day 0; stock waits 88 days to sell; customers pay about 38 days after that; and suppliers themselves are paid at 69 days — netting out to the 56-day cycle.
In money terms: at FY26 sales of ₹775 Cr, each day of the cycle holds about ₹2.1 Cr — so the 56-day loop keeps roughly ₹119 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹209 Cr over the last 3 fiscal years against ₹73.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹30.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified
Ultramarine & Pigments Ltd earns a ROCE of 11% in FY26. That is up from a trough of 9% in FY24. Return on invested capital clears the cost of that capital by −4.3 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 10.5% net margin on 0.71× asset turns.
FY26 ROCE is 11%, recovered from a FY24 trough of 9% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 10.5% net margin × 0.71× asset turns × 1.26× balance-sheet leverage ≈ 9.4% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: 7.7% − 12.0% = a −4.3 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified
Ultramarine & Pigments Ltd carries total debt of ₹86.0 Cr against shareholder equity of ₹870 Cr as of Mar 26, a debt-to-equity of 0.10 — effectively unlevered. On the annual view that ratio went from 0.06 in FY22 to 0.10 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of ₹86.0 Cr against shareholder equity of ₹870 Cr — a debt-to-equity of 0.10. On the annual view, debt-to-equity went from 0.06 (FY22) to 0.10 (FY26). The returns on this page are earned, not borrowed.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of Ultramarine & Pigments Ltd moved a full percentage point over the last two years — the register is quiet. Domestic institutions moved +0.3 points over the same window, to 0.6%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: −0.5 points over 8 quarters to 40.5%; Domestic institutions: +0.3 points over 8 quarters to 0.6%; Foreign institutions: +0.1 points over 8 quarters to 1.4%.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Ultramarine & Pigments Ltd: the Z-score reads 5.51. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 5.51 sits well clear of the distress zone — the balance sheet is not the risk here.
The safety line in one sentence: the Z-score reads 5.51.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Bhageria Industries LtdBHAGERIA | 71.2/100Favorable setup87% evidence | LEADER | 30.2/35 Revenue 57% · PAT 55.8% · OPM change 4 pp 95% evidence | 14.4/25 ROCE 9.4% · OPM 15% 95% evidence | 9.0/20 P/E 20.1× · PEG — 50% evidence | 17.6/20 RS sector 26.3% · RS bench 70.5% · 1Y 59.4%12 of 12 weeks ahead 100% evidence |
| Exact sum: 30.2 + 14.4 + 9 + 17.6 = 71.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Ultramarine & Pigments Ltdthis pageULTRAMAR | 66.2/100Favorable setup81% evidence | TURNING | 23.0/35 Revenue 15.6% · PAT 16.5% · OPM change 2 pp 95% evidence | 17.3/25 ROCE 10.8% · OPM 19% 95% evidence | 13.3/20 P/E 13.9× · PEG — 50% evidence | 12.6/20 RS sector 9.3% · RS bench 3.6% · 1Y -8.5%2 of 9 weeks ahead 70% evidence |
| Exact sum: 23 + 17.3 + 13.3 + 12.6 = 66.2 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 3Atul LtdATUL | 62.3/100Mixed-positive evidence100% evidence | ASLEEP | 27.4/35 Revenue 15.8% · PAT 56.3% · OPM change 5 pp 100% evidence | 18.0/25 ROCE 14.9% · OPM 21% 100% evidence | 15.1/20 P/E 23.1× · PEG 0.69 100% evidence | 1.8/20 RS sector -27.2% · RS bench -0.4% · 1Y -0.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 27.4 + 18 + 15.1 + 1.8 = 62.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -27.2% and the one-year return is -0.9%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 4Bodal Chemicals LtdBODALCHEM | 58.8/100Mixed-positive evidence80% evidence | TURNING | 21.2/35 Revenue 27.6% · PAT 100% · OPM change 0 pp 95% evidence | 8.3/25 ROCE 5.6% · OPM 10% 95% evidence | 9.3/20 P/E 31.6× · PEG — 15% evidence | 20.0/20 RS sector 101.8% · RS bench 169.2% · 1Y 164.7%4 of 12 weeks ahead 100% evidence |
| Exact sum: 21.2 + 8.3 + 9.3 + 20 = 58.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Vidhi Specialty Food Ingredients LtdVIDHIING | 52.0/100Mixed-positive evidence81% evidence | BREAKING OUT | 14.7/35 Revenue 12.9% · PAT 10.4% · OPM change -5 pp 95% evidence | 17.8/25 ROCE 18.8% · OPM 18% 95% evidence | 10.7/20 P/E 31.4× · PEG — 50% evidence | 8.8/20 RS sector -9.9% · RS bench 5.3% · 1Y -13.3%5 of 10 weeks ahead 70% evidence |
| Exact sum: 14.7 + 17.8 + 10.7 + 8.8 = 52 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Kiri Industries LtdKIRIINDUS | 48.5/100Mixed-negative evidence75% evidence | BREAKING OUT | 22.4/35 Revenue 25% · PAT 100% · OPM change 13 pp 95% evidence | 5.3/25 ROCE -1.7% · OPM 5% 76% evidence | 11.5/20 P/E 4.4× · PEG — 15% evidence | 9.3/20 RS sector -15.7% · RS bench 15.1% · 1Y 2.7%4 of 12 weeks ahead 100% evidence |
| Exact sum: 22.4 + 5.3 + 11.5 + 9.3 = 48.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Sudarshan Chemical Industries LtdSUDARSCHEM | 43.4/100Mixed-negative evidence94% evidence | BREAKING OUT | 19.8/35 Revenue 90.2% · PAT 2.3% · OPM change 2 pp 100% evidence | 7.8/25 ROCE 5.5% · OPM 10% 100% evidence | 6.9/20 P/E 97.8× · PEG 1.42 100% evidence | 8.9/20 RS sector -13.2% · RS bench 25.7% · 1Y -12.4%10 of 10 weeks ahead 70% evidence |
| Exact sum: 19.8 + 7.8 + 6.9 + 8.9 = 43.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Sudarshan Colorants India LtdSUDARCOLOR | 37.0/100Mixed-negative evidence87% evidence | BREAKING OUT | 6.8/35 Revenue -8.1% · PAT -25.4% · OPM change 0 pp 95% evidence | 14.5/25 ROCE 11.4% · OPM 12% 95% evidence | 14.1/20 P/E 16.9× · PEG — 50% evidence | 1.6/20 RS sector -30.7% · RS bench -5.6% · 1Y -36.3%6 of 12 weeks ahead 100% evidence |
| Exact sum: 6.8 + 14.5 + 14.1 + 1.6 = 37 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 9Sadhana Nitro Chem LtdSADHNANIQ | 31.4/100Adverse evidence69% evidence | BREAKING OUT | 9.2/35 Revenue -69% · PAT -80% · OPM change 1.6 pp 71% evidence | 3.5/25 ROCE -11.1% · OPM 8.5% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 8.7/20 RS sector -3.7% · RS bench 29.7% · 1Y 5.9%12 of 12 weeks ahead 100% evidence |
| Exact sum: 9.2 + 3.5 + 10 + 8.7 = 31.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Indokem LtdINDOKEM | 30.9/100Adverse evidence74% evidence | 6.8/35 Revenue -4.5% · PAT -57.5% · OPM change 0.5 pp 95% evidence | 2.5/25 ROCE 5.5% · OPM 4.8% 95% evidence | 8.5/20 P/E 764× · PEG — 15% evidence | 13.1/20 RS sector 27.1% · RS bench 0.7% · 1Y 27.4%6 of 12 weeks ahead 70% evidence | |
| Exact sum: 6.8 + 2.5 + 8.5 + 13.1 = 30.9 · Decision use: Price leads the evidence: RS versus the benchmark is 0.7%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Ultramarine & Pigments Ltd's share price today?
Ultramarine & Pigments Ltd trades at ₹428, −8.4% over the past year. The company is valued at ₹1,251 Cr. The stock sits at 58% of its 52-week range of ₹367–₹472, +3.2% versus its 200-day average. On the tape, the price is in a downtrend, 50 weeks in. — as of 11 September 2026.
What were Ultramarine & Pigments Ltd's latest quarterly results?
Ultramarine & Pigments Ltd reported revenue of ₹240 Cr and net profit of ₹32.0 Cr for the Jun 26 quarter. Revenue rose 30.4% and profit rose 60.0% year on year. Earnings per share were ₹10.82. The operating margin was 19.0%, 2.0 pp higher than a year earlier. — as of 11 September 2026.
What is Ultramarine & Pigments Ltd's revenue?
Ultramarine & Pigments Ltd reported revenue of ₹240 Cr in the Jun 26 quarter, +30.4% year on year. For the full FY26 fiscal year, revenue was ₹775 Cr (+11.5%). Over the last 6 years revenue compounded at 16.8% a year. — as of 11 September 2026.
What is Ultramarine & Pigments Ltd's profit?
Ultramarine & Pigments Ltd earned ₹32.0 Cr of net profit in the Jun 26 quarter, +60.0% year on year. Full-year FY26 profit was ₹81.0 Cr. The operating margin ran 19.0% in the latest quarter. — as of 11 September 2026.
What is Ultramarine & Pigments Ltd's market cap?
Ultramarine & Pigments Ltd's market capitalisation is ₹1,251 Cr at a share price of ₹428. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is Ultramarine & Pigments Ltd's P/E ratio?
Ultramarine & Pigments Ltd trades at a P/E of 13.9×, at the 18th percentile of its own 6-year range, against a long-run median of 16.8×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does Ultramarine & Pigments Ltd pay a dividend?
Yes — Ultramarine & Pigments Ltd's dividend payout was 22% of profit in FY26, and it recorded a payout in each of its last 7 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.
Is Ultramarine & Pigments Ltd overvalued?
On its own history, Ultramarine & Pigments Ltd looks cheap: its P/E of 13.9× has been cheaper only 18% of the time in 6 years (long-run median 16.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.
Is Ultramarine & Pigments Ltd growing?
Yes — Ultramarine & Pigments Ltd is growing: latest-quarter revenue +30.4% year on year, profit +60.0%, and the margin +2.0 pp at 19.0%. The 6-year compound rates are 16.8% (revenue) and 4.6% (profit). The earnings engine currently reads: improving — as of 11 September 2026.
How is Ultramarine & Pigments Ltd performing?
Ultramarine & Pigments Ltd is in a downtrend, 50 weeks in. Its latest quarter's revenue rose 30.4% and profit rose 60.0% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 4 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is Ultramarine & Pigments Ltd in?
Mixed — no clean majority across the growth curves, ROCE holding at 11.0% — the per-curve reads carry the story. The read comes from the last 12 quarters of growth (revenue growth +15.6% latest, profit growth +16.5% latest, eps growth +17.2% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is Ultramarine & Pigments Ltd in an uptrend?
No — the price is in a downtrend (week 50 of stage 4), trading +3.2% versus its 200-day average and at 58% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is Ultramarine & Pigments Ltd beating the market?
On recent form, yes — Ultramarine & Pigments Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 4 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +277% against the NIFTY 500's +267% — ahead of the index over the full window. — as of 11 September 2026.
Will Ultramarine & Pigments Ltd's share price go up?
This page publishes no price forecast for Ultramarine & Pigments Ltd. What it measures instead: the share price is ₹428, the price is in a downtrend 50 weeks in. Its P/E of 13.9× sits at the 18th percentile of its own 6-year range. — as of 11 September 2026.
Who owns Ultramarine & Pigments Ltd?
Promoters hold 40.5% of Ultramarine & Pigments Ltd, foreign institutions 1.4%, domestic institutions 0.6% and the public 57.5% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 11 September 2026.
Does Ultramarine & Pigments Ltd have too much debt?
No — Ultramarine & Pigments Ltd's debt-to-equity is 0.10, and operating profit covers the interest bill 18×. FY26 borrowings were ₹86.0 Cr against equity of ₹870 Cr. The returns on this page are earned, not borrowed — as of 11 September 2026.
What is Ultramarine & Pigments Ltd's capex?
Ultramarine & Pigments Ltd spent ₹209 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹70.0 Cr, with ₹30.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.
What is Ultramarine & Pigments Ltd's cash flow?
Ultramarine & Pigments Ltd generated ₹128 Cr of operating cash flow in FY26 and ₹58.0 Cr of free cash flow after ₹70.0 Cr of capital spending. Reported profit that year was ₹81.0 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 11 September 2026.
Is Ultramarine & Pigments Ltd's profit real cash?
Yes — over the last 3 fiscal years, 138% of Ultramarine & Pigments Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹128 Cr against reported profit of ₹81.0 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 11 September 2026.
How financially safe is Ultramarine & Pigments Ltd?
On the balance sheet, the Z-score reads 5.51 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 11 September 2026.
Where is Ultramarine & Pigments Ltd in its business cycle?
Ultramarine & Pigments Ltd's FY26 operating margin was 16.0%, against a 7-year band of 16.0%–25.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 19.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What growth does Ultramarine & Pigments Ltd's price assume?
At its price on 13 June 2026, Ultramarine & Pigments Ltd was priced for profit growth of about 6.7% a year. Profit itself has compounded 4.6% a year over the past 6 years. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 11 September 2026.
What could break the Ultramarine & Pigments Ltd story?
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is Ultramarine & Pigments Ltd a stock worth studying right now?
This is not investment advice. The machine read: Ultramarine & Pigments Ltd's earnings have outrun its stock. EPS grew +7.6% in a year against a −8.4% price move. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!